Examining the impact of non-fatal overdoses on health outcomes and healthcare use among people with and without HIV.
The non-fatal overdose crisis: Sex and gender differences in healthcare utilization and health outcomes of people living with and without HIV between 2012 and 2020
This study looks at how non-fatal overdoses impact people with and without HIV, especially focusing on differences between men and women, to better understand their healthcare needs and outcomes.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Simon Fraser University NIH-funded |
| Lab location | 1 site (Burnaby, Canada) |
| Project ID | NIH-10879165 on NIH RePORTER |
What this research studies
This research investigates how non-fatal overdoses affect individuals living with and without HIV, focusing on differences based on sex and gender. By utilizing a comprehensive dataset from British Columbia's healthcare system, the study aims to analyze healthcare utilization and health outcomes from 2012 to 2020. It seeks to understand the long-term impacts of non-fatal overdoses, particularly how they differ between men and women, and how these differences may influence healthcare access and outcomes. The findings could provide valuable insights into the healthcare needs of these populations.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults aged 21 and older who have experienced non-fatal overdoses, particularly those living with HIV.
Not a fit: Patients who have not experienced non-fatal overdoses or who are under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved healthcare strategies and interventions tailored to the specific needs of individuals affected by non-fatal overdoses, particularly those living with HIV.
How similar studies have performed: Previous research has indicated significant gender differences in health outcomes related to overdoses, suggesting that this approach could yield important insights.
Where this research is happening
Burnaby, Canada
- Simon Fraser University — Burnaby, Canada (Active)
Researchers
- Principal investigator: Hogg, Robert S — Simon Fraser University
- Study coordinator: Hogg, Robert S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.